Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00743327 · ClinicalTrials.gov registry record
Androgen Deprivation Therapy Study
A clinical trial, sponsored by National Institute on Aging (NIA).
- Terminated
- Registry status
- 1
- Enrollment target
NCT00743327: Clinical Trial study, sponsored by National Institute on Aging (NIA).
NCT00743327 is a clinical trial that was terminated before completion, run by National Institute on Aging (NIA). The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00743327 was terminated before completion, sponsored by National Institute on Aging (NIA).
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the link between low testosterone and insulin resistance/diabetes in men undergoing androgen deprivation therapy for prostate cancer. The study will also evaluate other cardiovascular risk factors in these men.
Interventions
- DRUG Pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-08 |
Why NCT00743327 stopped before completion
NCT00743327 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pioglitazone is the first listed.
NCT00743327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00743327 about?
NCT00743327 is a clinical study titled "Androgen Deprivation Therapy Study". The purpose of this study is to examine the link between low testosterone and insulin resistance/diabetes in men undergoing androgen deprivation therapy for prostate cancer. The study will also evaluate other cardiovascular risk factors in these men.
What is the current status of trial NCT00743327?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2008-10. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00743327?
The interventions under investigation include: Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00743327?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia